Research and Capacity Building in Antimicrobial Resistance in West Africa
Project Number5D43TW012487-03
Contact PI/Project LeaderSAMPANE-DONKOR, ERIC
Awardee OrganizationUNIVERSITY OF GHANA
Description
Abstract Text
ABSTRACT
Antimicrobial resistance (AMR) is considered by the World Health Organization as one of the
greatest global threats to human health in recent times and limits achievement of several of the
Sustainable Development goals, in particular SDG3 (Ensure healthy lives and promote well-being
for all at all ages). Although the burden of AMR disproportionately affects western sub-Saharan
Africa, research capacity in the sub-region is very low and not well positioned to tackle the current
demands of the problem. There is an acute shortage of professionals in West Africa in crucial
areas that are essential to impact research, policy and disease control. There is a dearth of
expertise for an array of crucial specialization relevant to AMR such as genomics, bioinformatics
and population genetics compared to other African regions. These research capacity deficiencies
could be addressed by focusing on long-term institutional training of junior scientists locally.
However, currently, there are hardly any academic training programs in West Africa countries that
focus on AMR. The objective of the proposed training programme is to increase research into the
detection, prevention and treatment of drug-resistant infections in West Africa, expand knowledge
and skills in clinical microbiology, and help junior scientists find a viable career path in AMR
research. The long-term goal is to establish a core of West African scientists who advance the
understanding and management of AMR and to support them to be competitive in obtaining
research grants from international funding agencies such as the National Institutes of Health, USA
and The Wellcome Trust, UK.
Public Health Relevance Statement
PROJECT NARRATIVE
The objective of the proposed training program is to increase research into the detection, prevention
and treatment of drug-resistant infections in West Africa, and expand knowledge and skills in clinical
microbiology. The program involves providing a rigorous PhD student training, and offering tailored
training to junior scientists and faculty from West Africa, in antimicrobial resistance. The major
outcome will be a significant increase in antimicrobial resistance research capacity in the West
African sub-region.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Academic TrainingAchievementAcuteAddressAffectAfricaAfrica South of the SaharaAfricanAgeAntimicrobial ResistanceAreaBioinformaticsCareer ChoiceClinical MicrobiologyCountryDetectionDrug resistanceEnsureFunding AgencyGenomicsGoalsHealthHumanInfectionInstitutionInternationalKnowledgePersonal SatisfactionPoliciesPopulation GeneticsPositioning AttributePreventionResearchResearch Project GrantsScientistSustainable DevelopmentTrainingTraining ProgramsTrustUnited States National Institutes of HealthWorld Health Organizationdisorder controlskills
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
989
DUNS Number
552641664
UEI
FWUVUCDMQ7M1
Project Start Date
15-April-2023
Project End Date
31-December-2027
Budget Start Date
01-January-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$246,314
Direct Costs
$229,550
Indirect Costs
$16,764
Year
Funding IC
FY Total Cost by IC
2025
John E. Fogarty International Center for Advanced Study in the Health Sciences
$246,314
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5D43TW012487-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5D43TW012487-03
Patents
No Patents information available for 5D43TW012487-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5D43TW012487-03
Clinical Studies
No Clinical Studies information available for 5D43TW012487-03
News and More
Related News Releases
No news release information available for 5D43TW012487-03
History
No Historical information available for 5D43TW012487-03
Similar Projects
No Similar Projects information available for 5D43TW012487-03